Top compounds associated with response to FNDC9


Feature Type Standardized
Nominal ANOVA
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.17 4e-05
mRNA manumycin A CTRPv2 pan-cancer AAC 0.15 6e-05
mRNA prima-1 CTRPv2 pan-cancer AAC 0.14 7e-05
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.15 9e-05
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.15 9e-05
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA RO4929097 CTRPv2 pan-cancer AAC 0.23 0.0001
mRNA GSK2636771 CTRPv2 pan-cancer AAC 0.18 0.0001
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.16 0.0001
Download CSV